Insider trade

Tyra Biosciences (TYRA): CFO bought ~$152K

Alan Fuhrman, CFO at Tyra Biosciences, bought ~$152K of Tyra Biosciences shares.

~$152K
Approx. value · 9,500 sh @ $16.00
13K
Holds after · shares reported
Traded
Oct 30, 2024
Filed
Nov 1, 2024

What stands out in this filing

  • The purchase added 283.7% to the shares this insider held before it; the filing reports 12,849 shares afterwards.
  • 9,500 shares at an average of $16.00 each, as reported on the form.
  • No other open-market purchase by this insider in 12 months of filings.
  • 1 other insider at TYRA also bought in the open market within 30 days.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 30, 2024InsiderCEO sold ~$12K of TYRA shares in the open market
  2. Oct 15, 2024InsiderCEO sold ~$244K of TYRA shares in the open market
  3. Oct 16, 2024Insider · 1 personInsiders: 3 sales (~$871K)
  4. Oct 17, 2024Insider · 1 personInsiders: 2 sales (~$398K)
  5. Oct 18, 2024InsiderCEO sold ~$1.18M of TYRA shares in the open market
  6. Oct 21, 2024Insider · 1 personInsiders: 2 sales (~$532K)
  7. Oct 30, 2024 · this disclosureInsiderCFO purchased ~$152K of TYRA shares in the open market

What came next

  1. Oct 30, 2024Insider · 1 personInsiders: 2 sales (~$179K)
  2. Oct 31, 2024Insider · 1 personInsiders: 2 sales (~$1.6M)
  3. Nov 1, 2024Insider · 1 personInsiders: 4 sales (~$455K)
  4. Nov 4, 2024Insider · 1 personInsiders: 2 sales (~$18K)
  5. Nov 5, 2024Insider · 1 personInsiders: 2 sales (~$176K)
  6. Nov 6, 2024Insider · 1 personInsiders: 2 sales (~$902K)
  7. Nov 7, 2024Insider · 1 personInsiders: 2 sales (~$383K)
  8. Nov 8, 2024InsiderDirector purchased ~$19.8M of TYRA shares in the open market
  9. Nov 25, 2024Insider · 1 personInsiders: 2 sales (~$89K)
  10. Jan 16, 2025Insider · 1 personInsiders: 2 sales (~$127K)
  11. Jan 17, 2025Insider · 1 personInsiders: 2 sales (~$218K)
  12. Jan 21, 2025InsiderDirector sold ~$65K of TYRA shares in the open market
  13. Jan 23, 2025InsiderDirector sold ~$78K of TYRA shares in the open market
  14. Feb 5, 2025Insider · 1 personInsiders: 2 sales (~$74K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Tyra Biosciences

OQRO holds no insider, Congress, fund or contract record for Tyra Biosciences dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TYRA page.

How this filing works

Explore the data

Common questions

Which Tyra Biosciences (TYRA) insider traded, and how much?

Alan Fuhrman, CFO at Tyra Biosciences, bought ~$152K of Tyra Biosciences shares. 9,500 shares at $16.00, open market.

When did it happen, and when was it made public?

Traded: Oct 30, 2024. Filed: Nov 1, 2024. That is 2 days between the two dates.

What stands out in this filing?

The purchase added 283.7% to the shares this insider held before it; the filing reports 12,849 shares afterwards. 9,500 shares at an average of $16.00 each, as reported on the form. No other open-market purchase by this insider in 12 months of filings.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

Does this mean TYRA stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Tyra Biosciences

Everything OQRO holds on this company is on its TYRA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data